• MUHAMMAD RUSDA Division of Fertility, Endocrinology and Reproductive Medicine, Department of Obstetric and Gynecology, Faculty of Medicine, Universitas Sumatera Utara



Nigella sativa, Antifungal, Candida albicans, Fungal inoculation, Pseudoestrus, Vulvovaginal candidiasis, Fluconazole


Objective: To assess the antifungal effect of Nigella sativa extract on female Wistar rats vulvovaginal candidiasis.

Methods: This was an analytic study that assess the therapeutic effect of Nigella sativa in rats’ vulvovaginal candidiasis model. The subjects were 28 rats that had been inoculated with Candida albicans and divided into 4 groups: control group (G1), fluconazole group (G2), Nigella sativa group (G3) and combination of Nigella sativa with fluconazole group (G4). Candida albicans colony was measured to assess the therapeutic effect of the treatment.

Results: There were no difference number of Candida albicans colony between all group before inoculation (p = 0,274) and after inoculation (p = 0,323). There were a significant decreased number of Candida albicans colony on the 72 h after the treatment between the three types of treatment with the control group (Nigella sativa group p = 0,002; Fluconazole group p = 0,001; Nigella sativa+fluconazole p = 0,001)

Conclusion: Nigella sativa has a potential antifungal effect by reducing the number of Candida albicans colonies.


Download data is not yet available.


1. Association for Genitournary Medicine. National guideline on the management of vulvovaginal candidiasis; 2002.
2. Bitew A, Abebaw. Vulvovaginal candidiasis: species distribution of candida and their antifungal susceptibility pattern. Bmc Women’s Health 2018;18:1–10.
3. Cassone A, Sobel JD. Experimental models of vaginal candidiasis and their relevance to human candidiasis. Infect Immun 2016;84:1255–61.
4. Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi KA, Siddique NA, et al. A review on therapeutic potential of nigella sativa: a miracle herb. Asian Pacific J Trop Biomed 2013;3:337–52.
5. Fard FA, Zahrani ST, Bagheban AA, Mojab F. Therapeutic effects of nigella sativa linn (Black Cumin) on candida albicans vaginitis. Arch Clin Infect Dis 2015;10:1–5.
6. Forouzanfar F, Fazly Bazzaz BS, Hosseinzadeh. Black cumin (Nigella Sativa) and its constituent (Thymoquinone): a review on antimicrobial effects. Iranian J Basic Med Sci 2014;17:929–38.
7. Kooti W, Hasanzadeh Noohi Z, Sharafi Ahvazi N, Ashtary Larky D. Phytochemistry, pharmacology, and therapeutic uses of black seed (Nigella sativa). China Pharmaceutical 2016;14:732-45.
8. Moghim H, Taghipoor S, Shahinfard N, Kheiri S, Panahi R. Antifungal effects of zataria multiflora and nigella sativa extracts against candida albicans. J Herb Med Pharmacol 2015;4:138–41.
9. Shokri H. A review on the inhibitory potential of nigella sativa against pathogenic and toxigenic fungi. Avicenna J Phytomed 2016;6:21–33.
10. Martinez RC, Franceschini SA, Patta MC, Quintana SM, Candido RC, Ferreira JC. Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic lactobacillus rhamnosus GR-1 and lactobacillus reuteri RC-14. Lett App Microbiol 2009;48:269–74.
11. Fidel PL, Cutright J, Steele C. Effects of reproductive hormones on experimental vaginal candidiasis. Infection Immunity 2000;68:651-7.
12. Joly V, Yeni P. Rodent models of candida sepsis. In: Handbook of animal models of infection. Zak O, Sande M. Eds. Academic press: Cambridge, MA USA; 1999. p. 650–7.
13. Mohammed AENA, Al-Suwaieg SB. Effects of nigella sativa on mammals’ health and production. Adv Anim Vet 2016;4:1–7.
14. Tavakkoli A, Mahdian V, Razavi B. Hosseinzadeh. Review on clinical trials of black seed (Nigella Sativa) and its active constituent, thymoquinone. J Pharmacopuncture 2017;20:179–93.
15. Gharby S, Harhar, Guillaume D, Roudani A, Boulbaround S, Ibrahimi M, et al. Chemical investigation of nigella sativa L. seed oil produced in morocco. J Saudi Soc Agric Sci 2015;14:172-7.



How to Cite

RUSDA, M. “ANTIFUNGAL EFFECT OF NIGELLA SATIVA EXTRACT ON FEMALE WISTAR RATS VULVOVAGINAL CANDIDIASIS MODEL”. International Journal of Current Pharmaceutical Research, vol. 12, no. 3, May 2020, pp. 66-68, doi:10.22159/ijcpr.2020v12i3.38308.



Original Article(s)